MAP2K1 and androgen insensitivity syndrome: It should be noted that this is the first clinical report of MAP2K1 E102_I103del as a hotspot mutation in AIS; therefore, we are unsure whether this observation is only specific to our population or it is due to the large AIS cohort included in our cohort (n = 246) compared to earlier studies.